P1.04-14 Early Changes in Plasma CXCL2 and MMP2 Levels Predicts the Response to Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer

Authors :: N. Matsuo
K. Azuma
K. Murotani
H. Ishii
T. Tokito
K. Yamada
Y. Shibata
T. Shimokawaji
Y. Nakahara
T. Kondo
T. Kato
H. Saito
T. Sasada
T. Hoshino
Source :: Journal of Thoracic Oncology. 14:S444
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
CXCL2
MMP2
Oncology
business.industry
Anti pd 1
Cancer research
medicine
Non small cell
Lung cancer
medicine.disease
business

Full Text Access

Tools